Nurix Therapeutics, Inc. NRIX Total debt

Total debt at other companies

ArvinasARVN

$8.6M-19.6%

Kymera TherapeuticsKYMR

$80.14M-8.5%

Monte Rosa Therapeutics, Inc.GLUE

$37.99M-7.6%

Septerna, Inc.SEPN

$23.09M-7.7%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

Apogee Therapeutics, Inc.APGE

$8.05M-31.9%

FAQ

What is Nurix Therapeutics, Inc.'s total debt?

Nurix Therapeutics, Inc. (NRIX) reported total debt of $58.14M in Q1 2026.

How has Nurix Therapeutics, Inc.'s total debt changed year-over-year?

Nurix Therapeutics, Inc.'s total debt increased by 12.0% year-over-year, from $51.93M to $58.14M.

What is the long-term trend for Nurix Therapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total debt has grown at a 31.4% compound annual growth rate (CAGR), from $14.25M to $55.73M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.